SCM
CLYM

Sterling Capital Management’s Climb Bio CLYM Stock Holding History

Sterling Capital Management’s Portfolio CLYM Stock Details CLYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-479
Closed -$584 – 3430
2025
Q1 		$584 Sell
479
-462
-49% -$749 ﹤0.01% 2939
2024
Q4 		$1.69K Buy
941
+829
+740% +$3K ﹤0.01% 2823
2024
Q3 		$570 Buy
+112
New +$792 ﹤0.01% 2804

Other funds holding CLYM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return

Sterling Capital Management's CLYM Position: Q2 2025 in Review

Sterling Capital Management sold out of Climb Bio (CLYM) in Q2 2025, closing a stake of 479 shares — an estimated $584 sold.

Sterling Capital Management first reported a position in CLYM in Q3 2024 and held it in 3 quarters. The position peaked at $1.69K in Q4 2024. 69 funds tracked by Wall St. Rank hold CLYM as of Q2 2025.

  • Sterling Capital Management reported no remaining Climb Bio position as of Q2 2025 after selling out during the quarter.
  • Sterling Capital Management sold 479 Climb Bio shares in Q2 2025, an estimated $584.
  • Sterling Capital Management first reported a position in Climb Bio in Q3 2024 and held it in 3 quarters.
  • Sterling Capital Management's Climb Bio position peaked at $1.69K in Q4 2024.
  • 69 funds tracked by Wall St. Rank held Climb Bio as of Q2 2025.

Based on Sterling Capital Management's 13F filing for Q2 2025, filed 6 Aug 2025.